The best indicator for Baxter International (BAX)
We backtested 20 indicators across daily, weekly and hourly charts on real Baxter International (BAX) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Bollinger Mean-Reversion
On the daily chart, this is the strongest risk-adjusted edge we found for Baxter International (BAX) over ~44.6 years — trailing buy-and-hold by 0.7% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Bollinger Mean-Reversion ✓ | Daily | 5.4% | 0.41 | -53.6% | 71.9% | 196 | -0.7% |
| 2 | EMA 20/50 Cross ✓ | Weekly | 5.9% | 0.39 | -49.2% | 56.2% | 16 | -0.1% |
| 3 | EMA 50/200 Cross ✓ | Daily | 5.3% | 0.35 | -45.8% | 44.1% | 34 | -0.8% |
| 4 | Money Flow Index | Daily | 5.1% | 0.35 | -58.7% | 75.0% | 40 | -1.0% |
| 5 | Stochastic ✓ | Daily | 4.5% | 0.34 | -57.5% | 72.0% | 207 | -1.6% |
| 6 | SMA 50/200 Cross | Daily | 4.5% | 0.32 | -53.4% | 52.8% | 36 | -1.5% |
| 7 | Williams %R ✓ | Daily | 3.4% | 0.27 | -66.8% | 71.3% | 286 | -2.7% |
| 8 | WaveTrend (8/6/4) | Daily | 3.3% | 0.26 | -79.8% | 71.1% | 166 | -2.8% |
| 9 | CCI | Daily | 3.0% | 0.25 | -70.8% | 73.4% | 222 | -3.1% |
| 10 | Williams %R ✓ | Weekly | 2.8% | 0.25 | -64.7% | 80.0% | 55 | -3.3% |
| 11 | CCI ✓ | Weekly | 2.8% | 0.24 | -51.8% | 81.4% | 43 | -3.3% |
| 12 | RSI Trend (>50) | Weekly | 2.5% | 0.23 | -60.7% | 49.6% | 133 | -3.5% |
| 13 | Donchian Breakout | Weekly | 2.5% | 0.23 | -54.2% | 47.1% | 34 | -3.5% |
| 14 | Holy Grail Confluence ✓ | Daily | 1.4% | 0.17 | -70.2% | 75.8% | 62 | -4.7% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Baxter International (BAX), Bollinger Mean-Reversion on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.